TB-500 5 mgPack de 10 flacons5 en stockÉconomisez 20 %
En vedettepeptideintermediate5 en stock

TB-500 5 mg

Peptide de recherche liant l’actine

Buy TB-500 in Australia for actin-binding research. Lab-verified, lyophilised, Australian-shipped.

Strength
Dose
5mg / flacon
Forme
Poudre lyophilisée
Pack
Pack de 10 flacons

Usage exclusivement réservé à la recherche. Ce composé est vendu strictement pour la recherche in vitro et à des fins de laboratoire, et n’est pas destiné à la consommation humaine ni à un usage thérapeutique. En achetant, vous confirmez être un chercheur qualifié et acceptez notre avertissement complet.

160 € EUR
Économisez 20 %
Pack de 10 flacons
Avant 200 € EUR
Vendu en pack de 10 flacons

Plus que 5 packs

🧪Vérifié en laboratoire
✓Testé par un tiers
⚡Livraison mondiale rapide
🔒Paiement par carte sécurisé
Aperçu

Fragment de thymosine bêta-4 étudié pour la migration cellulaire, la régulation de l’actine et le remodelage tissulaire.

TB-500 is a synthetic peptide fragment of the naturally occurring protein thymosin β-4. The molecule contains the active actin-binding domain of full-length thymosin β-4 and has been extensively studied for its role in cell migration, wound-healing models, and tissue regeneration pathways. Quantum Labs supplies TB-500 as a lyophilised powder in sealed vials for Australian research applications.

TB-500 is most often studied alongside BPC-157 in tissue-repair research, where the two compounds target complementary mechanisms — BPC-157 acting predominantly through nitric oxide and VEGF pathways, TB-500 acting on actin sequestration and cytoskeletal remodelling. Our BPC-157 + TB-500 research stack supplies both compounds in pre-portioned vials.

Material ships from Australian stock, HPLC-verified to ≥99% purity with batch-level certificates of analysis available on request.

Mécanisme

Étudié pour sa liaison à la G-actine et son influence sur les marqueurs de migration cellulaire. La recherche suggère des bénéfices potentiels pour les voies de réparation tissulaire.

Rapport de laboratoire

Vérifié par HPLC selon une spécification de pureté ≥99 %. Analysé de manière indépendante par des laboratoires tiers accrédités.

Mechanism in research literature

TB-500 contains the LKKTETQ actin-binding sequence from thymosin β-4. In research models, this peptide region has been shown to modulate actin polymerisation, promote endothelial cell migration, and influence the differentiation of mesenchymal stem cells toward repair phenotypes. The full mechanism is still under investigation in pre-clinical literature.

FAQ chercheurs

TB-500 — questions fréquentes

What is TB-500?

TB-500 is a synthetic fragment of the naturally occurring protein thymosin β-4, containing the active actin-binding domain. It is supplied for laboratory research into cell-migration and tissue-repair pathways.

Is TB-500 legal in Australia?

TB-500 is restricted for compounded human therapeutic supply in Australia. Research-grade TB-500 supplied without therapeutic representation remains available for laboratory use. Quantum Labs supplies TB-500 for research use only.

What is the typical TB-500 research dosage?

Published animal studies have used TB-500 doses in the 2-10 mg/kg range for systemic models. Human therapeutic dosing is not established. Researchers should reference primary literature for protocol-specific dosing.

Can TB-500 be used with BPC-157?

Combined BPC-157 + TB-500 protocols are common in tissue-repair research. The two compounds are believed to act on complementary pathways — BPC-157 on nitric oxide and VEGF, TB-500 on actin and cell migration. Quantum Labs supplies a BPC-157 + TB-500 research stack in pre-portioned vials.

What's the difference between TB-500 and thymosin β-4?

Full-length thymosin β-4 is a 43-amino-acid endogenous protein. TB-500 is the shorter active fragment containing the LKKTETQ actin-binding sequence. The shorter fragment is more practical for research-grade synthesis and is the form most studied in pre-clinical tissue-repair literature.

How is TB-500 stored?

Lyophilised TB-500 is stable at 2-8°C in unopened sealed vials. Once reconstituted, the working solution is typically stored at 2-8°C and used within 30 days. Avoid freeze-thaw cycles.

Pour aller plus loin

Guides liés à TB-500

Composés associés

Les chercheurs explorent aussi